April 17th 2024
A recent study found that human papillomavirus vaccination when aged under 20 years, coupled with active surveillance for cervical intraepithelial neoplasia grade 2, significantly lowers the risk of cervical intraepithelial neoplasia grade 3 or cervical cancer.
FDA approves rilpivirine for pediatric patients with HIV-1, weighing 14 kg to 25 kg
March 20th 2024Administration of the HIV-1 specific, non-nucleoside reverse transcriptase inhibitor (NNRTI) to the indicated population can be done via 25 mg oral tablets or new 2.5 mg oral tablets, developed to help administration and weight-adjusted dosing for children.
CDC updates guidelines for diagnosing and treating STIs
August 10th 2021The Centers for Disease Control and Prevention (CDC) updated its guidelines for the treatment of sexually transmitted infections (STIs), notably for Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis, and pelvic inflammatory disease.
CDC STI treatment guideline updates
May 5th 2021A session of the American College of Obstetricians and Gynecologists 2021 annual meeting pointed to the dramatic increase in sexually transmitted infections (STIs) in the United States and presented highlights from the updated Centers for Disease Control and Prevention (CDC) STI guidelines.
Parents and health care providers need to cheerlead the HPV vaccine for their teens
August 3rd 2020The human papillomavirus (HPV) vaccine is the key to a major public health victory, but the vaccine coverage has been less than effective. A report offers some answer to how parental intent has made an impact.
Using an improvement program to improve Chlamydia trachomatis testing
July 8th 2020Clinicians may still use urine nucleic-acid amplification tests, despite the recommendation to use a more sensitive vaginal swab to test for Chlamydia trachomatis. A report looks at whether a quality improvement program could change that.
Secondary Syphilis in a Teenage Boy
August 1st 2007This rash on a teenage boy's palms began on his hands and spread to his torso and upper and lower extremities over several days. He had no pain or pruritus. Two weeks before the lesions appeared, he had experienced fatigue, fever, and myalgia of 1 week's duration.
Erratum: Update on treatment of primary syphilis
September 1st 2006The July 2006 issue, which featured an update on STDs, included a case on primary syphilis in a teenager (page 427). Therapy with intramuscular penicillin G (weekly for 3 weeks) or ceftriaxone (daily for 2 weeks) was recommended. However, the CDC's newly published guidelines on STD treatment recommend therapy with a single intramuscular dose of 2.4 million units of penicillin G.1 If the patient is allergic to penicillin, the alternative is therapy with doxycycline (100 mg orally bid for 14 days) or tetracycline (500 mg qid for 14 days). Ceftriaxone is not a recommended treatment for syphilis.
Sexually Transmitted Diseases:A Photo Quiz
July 1st 2006Fourteen-year-old JT is worried. During health class last week, he learned about the different sexually transmitted infections as well as about testicular self-examination. While practicing his monthly testicular examination in the shower, he noticed that he had a number of small growths on his penis. On further questioning, JT insists that he has never been sexually active with another person.